Northwell Health — New York, New York

Public research footprint of Northwell Health, compiled from the ClinicalTrials.gov public registry.

678

Registered studies

364

Active

188

Recruiting now

223

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Metastatic Bladder Clear Cell (Glycogen-Rich) Urothelial Carcinoma · Anatomic Stage II Breast Cancer AJCC v8 · B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative

Recently updated registry entries

NCT07215910 — Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for… (Recruiting)
NCT04858334 — APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following… (Recruiting)
NCT07061977 — Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Northwell Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.